tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

LLYEli Lilly

Health care · Pharmaceuticals · NYSE
Compare with peers → Embed
Revised numbers, fiscal years since 2020

3 numbers reported differently in a later 10-K

XBRL, 7 10-Ks
Numbers revised
3
changes of 0.5% or more
Restatements
0
the company said the earlier number was wrong (8-K item 4.02)
Largest change
+7.1%
Cash from operations, Fiscal year ending 2022-12-31

A change is a restatement (the company says the earlier number was wrong) or a recast: after selling a business, adopting an accounting rule or moving amounts between lines, companies redo past years. The later 10-K's notes say which.

Number by number

First reported, then reported again

Each number links to its 10-K
NumberPeriodFirst reportedLater reportedChangeWhy
Shareholders' equity
StockholdersEquity · link
At 2024-12-31 $14.19B
10-K filed 2025-02-19
$14.27B
10-K filed 2026-02-12
+0.6% Recast or revision
Cash from operations
NetCashProvidedByUsedInOperatingActivities · link
Fiscal year ending 2022-12-31 $7.08B
10-K filed 2023-02-22
$7.59B
10-K filed 2024-02-21
+7.1% Recast or revision
Cash from operations
NetCashProvidedByUsedInOperatingActivities · link
Fiscal year ending 2021-12-31 $7.26B
10-K filed 2022-02-23
$7.37B
10-K filed 2024-02-21
+1.4% Recast or revision

From SEC's XBRL company facts (7 10-K filings). Checked: revenue, operating income, net income, cash from operations, total assets, shareholders' equity, receivables and inventory. Per-share numbers are left out because stock splits change them.

Next Footnotes →